Concepedia

Publication | Open Access

Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition

DOIFull Paper Access

23

Citations

29

References

2023

Year

Efthymios Ziogos, Stephen P. Chelko, Tarek Harb, Morgan Engel, Michael Vavuranakis, Maicon Landim-Vieira, Elise M. Walsh, Marlene S. Williams, Shenghan Lai, Marc K. Halushka,
European Heart Journal - Cardiovascular Pharmacotherapy

Abstract

Proprotein Convertase Subtilisin/Kexin 9 inhibition decreases markers of platelet activation and endothelial dysfunction in ACS patients. PCSK9 is associated with platelets and vascular ECs in LIMA segments and PCSK9 inhibition decreases that interaction.

References

YearCitations

Page 1